These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1345984)

  • 21. Plasma-derived versus recombinant Factor VIII concentrates for the treatment of haemophilia A: recombinant is better.
    Franchini M
    Blood Transfus; 2010 Oct; 8(4):292-6. PubMed ID: 20967172
    [No Abstract]   [Full Text] [Related]  

  • 22. Modern treatment of hemophilia: from the shadows towards the light.
    Mannucci PM
    Thromb Haemost; 1993 Jul; 70(1):17-23. PubMed ID: 8236096
    [No Abstract]   [Full Text] [Related]  

  • 23. Hemophilia.
    Aledort LM
    N Engl J Med; 2001 Oct; 345(14):1066; author reply 1067. PubMed ID: 11586968
    [No Abstract]   [Full Text] [Related]  

  • 24. Pioneering therapeutic proteins in hemophilia care through innovative technologies.
    Pabinger-Fasching I; Négrier C
    Thromb Res; 2016 May; 141 Suppl 3():S1. PubMed ID: 27288062
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of recombinant antihemophilic factor in the treatment of two patients with classic hemophilia.
    White GC; McMillan CW; Kingdon HS; Shoemaker CB
    N Engl J Med; 1989 Jan; 320(3):166-70. PubMed ID: 2492083
    [No Abstract]   [Full Text] [Related]  

  • 26. Plasma-derived versus recombinant factor VIII concentrates for the treatment of haemophilia A: plasma-derived is better.
    Mannucci PM
    Blood Transfus; 2010 Oct; 8(4):288-91. PubMed ID: 20967171
    [No Abstract]   [Full Text] [Related]  

  • 27. Psychosocial issues surrounding the general or restricted use of recombinant factor VIII: hemophilia clinic perspective.
    McDonald JR
    Transfus Med Rev; 1992 Oct; 6(4):277-9. PubMed ID: 1421829
    [No Abstract]   [Full Text] [Related]  

  • 28. [Recombinant factor VIII].
    Tusell JM
    Sangre (Barc); 1993 Apr; 38(2):139-42. PubMed ID: 8516727
    [No Abstract]   [Full Text] [Related]  

  • 29. New-variant Creutzfeldt-Jakob disease and treatment of haemophilia. Executive Committee UK Haemophilia Directors' Organisation.
    Ludlam CA
    Lancet; 1998 Apr; 351(9111):1289-90. PubMed ID: 9643779
    [No Abstract]   [Full Text] [Related]  

  • 30. A practical guide to the evaluation and treatment of hemophilia.
    Furie B; Limentani SA; Rosenfield CG
    Blood; 1994 Jul; 84(1):3-9. PubMed ID: 8018925
    [No Abstract]   [Full Text] [Related]  

  • 31. The past and the future: recombinant factor VIII and the consumer.
    Isaac BM
    Transfus Med Rev; 1992 Oct; 6(4):280-3. PubMed ID: 1421830
    [No Abstract]   [Full Text] [Related]  

  • 32. Therapeutic choices in the current millennium: hemophilia workshop highlights.
    Mathew P; Manno CS; Aledort LM
    Pediatr Blood Cancer; 2005 Oct; 45(5):611-5. PubMed ID: 16127687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Future perspective for the treatment of hemophilia A.
    Laurian Y
    J Thromb Haemost; 2005 Jun; 3(6):1320-1. PubMed ID: 15946228
    [No Abstract]   [Full Text] [Related]  

  • 34. Recombinant blood clotting proteins for hemophilia therapy.
    Limentani SA; Roth DA; Furie BC; Furie B
    Semin Thromb Hemost; 1993; 19(1):62-72. PubMed ID: 8456325
    [No Abstract]   [Full Text] [Related]  

  • 35. Choice of replacement therapy for hemophilia.
    Aledort LM
    J Thromb Haemost; 2003 Mar; 1(3):596. PubMed ID: 12871472
    [No Abstract]   [Full Text] [Related]  

  • 36. Choice of replacement therapy for hemophilia.
    Roberts HR
    J Thromb Haemost; 2003 Mar; 1(3):595. PubMed ID: 12871471
    [No Abstract]   [Full Text] [Related]  

  • 37. Lack of response to commercial factor VIII concentrate in hemophilia A.
    Rodgers GM; Ford MH
    Am J Hematol; 1991 Aug; 37(4):288. PubMed ID: 1907098
    [No Abstract]   [Full Text] [Related]  

  • 38. Who should receive recombinant factor VIII?
    Giangrande PL
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S25-7. PubMed ID: 9351533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemophilia--a treatment in crisis.
    Aledort LM; Hilgartner M; Lipton RA
    N Engl J Med; 1988 Oct; 319(15):1017. PubMed ID: 3138539
    [No Abstract]   [Full Text] [Related]  

  • 40. Factor VIII concentrate available for treatment of classical hemophilia.
    Jewett WR
    Ann N Y Acad Sci; 1975 Jan; 240():188-90. PubMed ID: 1053863
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.